Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 30Leukemia, Lymphocytic, Chronic, B-Cell 28Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 18Myelodysplastic Syndromes 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Multiple Myeloma 15Neoplasm Metastasis 13Lymphoma, Follicular 12Skin Neoplasms 11Lymphoma, Mantle-Cell 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Hodgkin Disease 10Congenital Abnormalities 10Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Myeloproliferative Disorders 8Blast Crisis 8Anemia, Refractory, with Excess of Blasts 8Neoplasms, Plasma Cell 7Lymphoma, Large B-Cell, Diffuse 7Kidney Neoplasms 7Burkitt Lymphoma 7Primary Myelofibrosis 6Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Large-Cell, Immunoblastic 6

Interventions

montanide ISA 51 3Temozolomide 3Ipilimumab 3Interleukin-2 3sargramostim 2incomplete Freund's adjuvant 2glembatumumab vedotin 2aldesleukin 2Vorinostat 2Sunitinib 2Paclitaxel 2MART-1 Antigen 2Lenalidomide 2Dacarbazine 2Cyclophosphamide 2Carboplatin 2CR011-vcMMAE 2Amplified Fragment Length Polymorphism Analysis 2trametinib 1poly ICLC 1omipalisib 1fludarabine phosphate 1fludarabine 1flt3 ligand protein 1entinostat 1cixutumumab 1cediranib 1cabozantinib 1aflibercept 1Taxes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Uveal Melanoma × fludarabine phosphate × Clear all
NCT01814046 2018-10-11

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
24 enrolled 13 charts
Dermatologic

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡